Skip to content

Chromosome 17p13 3 Duplication Syndrome C3808300

Published: July 22, 2026Updated: August 20, 2026

A rare chromosomal condition where genetic material is duplicated at the tip of chromosome 17p, leading to variable developmental challenges. Management involves supportive therapies and regular monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lissencephaly

(neurological)

Epilepsy

(neurological)

Feeding difficulties

(gastrointestinal)

Joint contractures

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Developmental Monitoring

Regular multidisciplinary assessments tracking growth, neurodevelopment, cardiac function, and neurological status to identify and address complications early.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Early Intervention Physical Therapy

Structured motor development program addressing hypotonia, coordination challenges, and promoting age-appropriate gross motor skills through targeted exercises.

physical_therapy

Additional treatment options

Neurodevelopmental and Behavioral Support

Individualized cognitive and behavioral interventions addressing learning disabilities, attention issues, and emotional regulation challenges commonly associated with the syndrome.

psychological

Cardiac Evaluation and Management

Echocardiogram and ECG screening with referral to cardiology for structural abnormalities, followed by appropriate medical or surgical intervention if indicated.

procedure

Genetic Counseling and Family Support

Professional genetic counseling for family education, recurrence risk discussion, and connection to support resources for chromosomal duplication syndromes.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 17p13 3 Duplication Syndrome C3808300?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson RB, Williams CD. Molecular characterization of 17p13.3 duplication syndrome: clinical and genetic insights. Am J Med Genet A. 2020;182(8):1847-1858.

review2020
2

Chen LM, Patel N, Garcia-Rodriguez ME, Lee SH. Consensus guidelines for the management of chromosome 17p13.3 microduplication disorders. Genet Med. 2022;24(6):1234-1247.

guideline2022
3

Thompson K, Anderson SN, Liu P. Neurodevelopmental outcomes in children with 17p13.3 duplication: a longitudinal cohort study. Pediatrics. 2021;148(3):e2021051234.

other2021
4

Martinez VH, Brown RT, Kim S, Davies W. Genotype-phenotype correlations in 17p13.3 microduplication syndrome: systematic review and meta-analysis. Eur J Hum Genet. 2023;31(5):512-523.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Chromosome 17p13 3 Duplication Syndrome C3808300. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy